Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Feb;108(2):544–548. doi: 10.1111/j.1476-5381.1993.tb12838.x

Investigations into the mechanism of vasoconstrictor action of the topical steroid betamethasone-17-valerate in the rat.

A Ahluwalia 1, R J Flower 1
PMCID: PMC1907985  PMID: 8448601

Abstract

1. The effect of topical betamethasone upon skin blood flow was investigated in the rat. Two types of vasodilator stimuli were used; local heating to the surface of the skin and intradermal application of inflammatory agents. Blood flow was measured by laser doppler velocimetry. 2. Topical betamethasone-17-valerate (1 g with an 18 h pretreatment) significantly inhibited the heat-induced vasodilatation in the rat skin, as also did systemically administered betamethasone (1 mg kg-1, 3 h pretreatment). 3. Angiotensin converting enzyme (ACE) inhibitors (captopril, 5 mg kg-1 and enalapril, 1 mg kg-1, 30 min pretreatments) were the only drugs out of several different types of systemically administered inhibitors and antagonists that were tested which also inhibited the heat-induced vasodilatation. Aprotinin (100,000 KIU kg-1, 5 min pretreatment) a serine protease inhibitor, significantly potentiated the heat-induced response. 4. Bradykinin (50 nmol per site), des-Arg9-bradykinin (5 nmol per site), substance P (0.1 nmol per site) and capsaicin (1 mumol per site) induced an increase in skin blood flow. 5. Topical betamethasone treatment resulted in a significant inhibition of the vasodilator response to des-Arg9-bradykinin, whereas captopril treatment inhibited the responses to substance P, capsaicin, bradykinin and des-Arg9-bradykinin. 6. Intradermal application of captopril (10-100 micrograms) also caused a dose-dependent inhibition of the heat-induced vasodilatation.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
544

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahluwalia A., Peers S. H., Flower R. J. Steroid inhibition of oedema formation in the rat skin. Br J Pharmacol. 1992 Jul;106(3):628–631. doi: 10.1111/j.1476-5381.1992.tb14386.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Amantea M., Tur E., Maibach H. I., Guy R. H. Preliminary skin blood flow measurements appear unsuccessful for assessing topical corticosteroid effect. Arch Dermatol Res. 1983;275(6):419–420. doi: 10.1007/BF00417347. [DOI] [PubMed] [Google Scholar]
  3. Bisgaard H., Kristensen J. K., Sondergaard J. A new technique for ranking vascular corticosteroid effects in humans using laser-Doppler velocimetry. J Invest Dermatol. 1986 Mar;86(3):275–278. doi: 10.1111/1523-1747.ep12285417. [DOI] [PubMed] [Google Scholar]
  4. Bouthillier J., Deblois D., Marceau F. Studies on the induction of pharmacological responses to des-Arg9-bradykinin in vitro and in vivo. Br J Pharmacol. 1987 Oct;92(2):257–264. doi: 10.1111/j.1476-5381.1987.tb11319.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Deblois D., Bouthillier J., Marceau F. Effect of glucocorticoids, monokines and growth factors on the spontaneously developing responses of the rabbit isolated aorta to des-Arg9-bradykinin. Br J Pharmacol. 1988 Apr;93(4):969–977. doi: 10.1111/j.1476-5381.1988.tb11487.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Marks R., Sawyer M. Glucocorticoid-induced vasoconstriction in human skin. An inhibitory role on phospholipase A2 activity. Arch Dermatol. 1986 Aug;122(8):881–883. [PubMed] [Google Scholar]
  7. ROCHA E SILVA M., ANTONIO A. Release of bradykinin and the mechanism of production of a "thermic edema (45 degrees C)" in the rat's paw. Med Exp Int J Exp Med. 1960;3:371–382. [PubMed] [Google Scholar]
  8. ROCHA E SILVA M., ROSENTHAL S. R. Release of pharmacologically active substances from the rat skin in vivo following thermal injury. J Pharmacol Exp Ther. 1961 Apr;132:110–116. [PubMed] [Google Scholar]
  9. Sachs L., Marks N. A highly specific aminotripeptidase of rat brain cytosol. Substrate specificity and effects of inhibitors. Biochim Biophys Acta. 1982 Sep 7;706(2):229–238. doi: 10.1016/0167-4838(82)90491-5. [DOI] [PubMed] [Google Scholar]
  10. Saria A. Substance P in sensory nerve fibres contributes to the development of oedema in the rat hind paw after thermal injury. Br J Pharmacol. 1984 May;82(1):217–222. doi: 10.1111/j.1476-5381.1984.tb16461.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Williams T. J., Peck M. J. Role of prostaglandin-mediated vasodilatation in inflammation. Nature. 1977 Dec 8;270(5637):530–532. doi: 10.1038/270530a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES